We have previously shown that HLA-C*04: 01 acts as a risk factor for nevirapine-induced SJS/TEN consistent with the role of the immune response in the pathogenesis of nevirapine hypersensitivity. Here, HLA-C is linked to toxic epidermal necrolysis.